Furthermore, immunostaining of human fatty liver samples with LIS1 antibody revealed the down-regulation of LIS1 expression (6/10) (Fig. 5X), suggesting reduced LIS1 expression may involve in the pathogenesis of fatty liver in human. This evidence concerns the gene PAFAH1B1 and Hepatic steatosis.